8
當(dāng)前位置：> 供求商機> Matriks Biotek代理
[供應(yīng)]Matriks Biotek代理 返回列表頁
貨物所在地：北京北京市
更新時間：2024-11-14 09:25:37
有效期：2024年11月14日 -- 2025年5月17日
已獲點擊：253
聯(lián)系我時，請告知來自 化工儀器網(wǎng)
您好, 歡迎來到化工儀器網(wǎng)！ 登錄| 免費注冊| 產(chǎn)品展廳| 收藏商鋪|
您好, 歡迎來到化工儀器網(wǎng)！ 登錄| 免費注冊| 產(chǎn)品展廳| 收藏商鋪|
貨物所在地：北京北京市
更新時間：2024-11-14 09:25:37
有效期：2024年11月14日 -- 2025年5月17日
已獲點擊：253
聯(lián)系我時，請告知來自 化工儀器網(wǎng)
北京百奧創(chuàng)新Matriks Biotek代理業(yè)務(wù)。Matriks Biotek代理， Matriks Biotek北京代理， Matriks Biotek華東代理，Matriks Biotek華北代理，Matriks Biotek華中代理，Matriks Biotek華南代理。
MatriksBiotek®Co，是一家成立于2002年的生物技術(shù)公司。公司致力于研究有助于健康的免疫基礎(chǔ)，分子和工具的研發(fā)。自從在市場上*生產(chǎn)和商業(yè)化以來，生物藥物測試SHIKARI®ELISA試劑盒已上市10年。在36個國家和30多家制藥公司使用我們的產(chǎn)品。在某些疾病中使用生物制劑（主要是人源化重組單克隆抗體）作為藥物引起每個單獨治療的人的有效性問題。監(jiān)測藥物水平和抗體在管理對重組和/或人源化抗體的反應(yīng)缺乏或喪失方面發(fā)揮著新的作用。公司的主要興趣領(lǐng)域如下：生物藥物測試；生物治療藥物和疾病的新標(biāo)志物；炎癥和免疫學(xué)；肥胖，II型糖尿病和心血管疾??；傳染性疾?。荒[瘤科等
詳細產(chǎn)品列表：Matriks Biotek代理
貨號 | 產(chǎn)品 | 描述 |
TR-Q-INFLIXIv2 | Q-INFLIXI | Enzyme immunoassay for the quantitative determination of free Infliximab (Remicade®) in serum and plasma |
TR-ATIv5 | Q-ATI | Enzyme immunoassay for the qualitative determination of specific antibodies to infliximab in human serum and plasma with confirmation |
TR-ATIv6 | Q-ATI | Enzyme immunoassay for the quantitative determination of specific antibodies to infliximab in human serum and plasma with confirmation |
TR-ATIv8 | Q-ATI DUO | Enzyme immunoassay for the semi-quantitative determination (screening) of total and free antibodies to infliximab (Remicade®) in serum and plasma. |
TR-ADAv1 | Q-ADA | Enzyme immunoassay for the quantitative determination of free adalimumab (Humira®) in serum and plasma |
TR-AADAv1 | S-ATA | Enzyme immunoassay for the qualitative determination of antibodies to adalimumab (Humira®) in serum and plasma with confirmation |
TR-AADAv2 | S-ATA | Enzyme immunoassay for the quantitative determination of antibodies to adalimumab (Humira®) in serum and plasma with confirmation |
TR-AADAv4 | S-ATA DUO | Enzyme immunoassay for the semi-quantitative determination (screening) of total and free antibodies to adalimumab (Humira®) in serum and plasma |
TR-ETAv2 | Q-ETA | Enzyme immunoassay for the quantitative determination of free Etanercept (Enbrel) in serum and plasma |
TR-AETAv2 | S-ATE | Enzyme immunoassay for the qualitative determination of antibodies to etanercept in serum and plasma |
TR-BEVAv2 | Q-BEVA | Enzyme immunoassay for the quantitative determination of Bevacizumab (Avastin®) in serum and plasma |
TR-ARTXv2 | S-ATR | Enzyme immunoassay for the quantitative determination of antibodies to Rituximab® (Rituxan®, Mabthera®) in serum and plasma |
TR-TRASv2 | Q-TRAS | Enzyme immunoassay for the quantitative determination of Trastuzumab (Herceptin®, Herclon®) |
TR-ATRASv1 | S-ATT | Enzyme immunoassay for the qualitative determination of antibodies to Trastuzumab (Herceptin®, Herclon®) in serum and plasma |
TR-ATRASv2 | S-ATT | Enzyme immunoassay for the quantitative determination of antibodies to Trastuzumab (Herceptin®, Herclon®) in serum and plasma |
TR-GOLv1 | Q-GOL | Enzyme immunoassay for the quantitative determination of free Golimumab (Simponi®) in serum and plasma. |
TR-ATGv1 | S-ATG | Enzyme immunoassay for the qualitative determination of antibodies to Golimumab in serum and plasma. |
TR-CETv1 | Q-CET | Enzyme immunoassay for the quantitative determination of free Cetuximab (Erbitux®) in serum and plasma. |
TR-ATCv1 | S-ATC | Enzyme immunoassay for the qualitative determination of antibodies to cetuximab in serum and plasma. |
TR-ATCv2 | S-ATC | Enzyme immunoassay for the quantitative determination of antibodies to cetuximab in serum and plasma. |
TR-REMSv1 | Q-REMS | Enzyme immunoassay for the quantitative determination of free Infliximab (Remsima®) in serum and plasma. |
TR-AREMSv1 | S-AIR | Enzyme immunoassay for the qualitative determination of antibodies to Infliximab Remsima in serum and plasma. |
TR-AREMSv2 | S-AIR | Enzyme immunoassay for the quantitative determination of antibodies to Infliximab Remsima in serum and plasma. |
TR-AREMSv3 | S-AIR | Enzyme immunoassay for the semi-quantitative determination (screening) of total antibodies to Infliximab biosimilar (Remsima®) in serum and plasma. |
TR-QDENv1 | Q-DEN | Enzyme immunoassay for the quantitative determination of Denosumab (Prolia®)in serum and plasma. |
TR-AATDv1 | S-ATD | Enzyme immunoassay for the qualitative determination of antibodies to Denosumab in serum and plasma. |
TR-OMAv1 | Q-OMA | Enzyme immunoassay for the quantitative determination of Omalizumab (Xolair®) Remsima in serum and plasma. |
TR-AATOv1 | S-ATO | Enzyme immunoassay for the qualitative determination of antibodies to Omalizumab in serum and plasma. |
TR-Q-NIVOv1 | Q-NIVO | Enzyme immunoassay for the quantitative determination of Nivolumab (Opdivo®) in serum and plasma. |
TR-ATNv1 | S-ATN | Enzyme immunoassay for the qualitative determination of antibodies to Nivolumab in serum and plasma. |
TR-PEMv1 | Q-PEM | Enzyme immunoassay for the quantitative determination of Pembrolizumab (Keytruda®) in serum and plasma. |
TR-A-PEMv1 | S-ATP | Enzyme immunoassay for the qualitative determination of antibodies to Pembrolizumab in serum and plasma. |
TR-AFAv1 | Q-AFA | Enzyme immunoassay for the quantitative determination of specific anibodies to Filgrastim in serum and plasma. |
TR-IPIv1 | Q-IPI | Enzyme immunoassay for the quantitative determination of specific Ipilimumab(Yervoy®) in human serum and plasma. |
TR-AIPIv1 | S-ATI | Enzyme immunoassay for the qualitative determination of specific anibodies to Ipilimumab in serum and plasma. |
TR-Q-AVEv1 | Q-AVE | Enzyme immunoassay for the quantitative determination of specific Avelumab(Bavencio®) in human serum and plasma. |
TR-A-AVEv1 | S-ATAV | Enzyme immunoassay for the qualitative determination of specific anibodies to Avelumab in serum and plasma. |
TR-RANv1 | Q-RAN | Enzyme immunoassay for the quantitative determination of free Ranibizumab in aqueous humour. |
TR-RAMv1 | Q-RAM | Enzyme immunoassay for the quantitative determination of free Ramucirumab in serum and plasma. |
TR-ARAMv1 | S-ATRAM | Enzyme immunoassay for the qualitative determination of antibodies to Ramucirumab in serum and plasma. |
TR-CERTv1 | Q-CERT | Enzyme immunoassay for the quantitative determination of Certolizumab in human serum and plasma |
北京百奧創(chuàng)新科技有限公司：
一、輻射五大服務(wù)方向：
1.國內(nèi)試劑耗材經(jīng)銷代理；
2.國外試劑訂購（直訂，或境外代理）；
3.基因組測序（二代，二代+三代）；
4.基因分型（SNP檢測）：低/中/中 高通量項目；
5.生物樣本運輸（國內(nèi)、）；
二、多家*代理品牌，涉及30多種，經(jīng)營代理500多個品牌：
Qiagen、Sigma、R&D、Epigentek、ThermoFisher、DNA Genotek、USA Scientific、
Matreya、Sage Science、List Labs、Macrocyclics、Steraloids、
NIBSC、mobio、immunodx、cellsystems、medicago、abcam
CST、Roche、Bethyl、sino Biological、clodrosome、adi
BIO-WORLD、TOKU-E、HYPHEN BioMed、moltox、ZeptoMetrix
International Humic、biocytex、Toxin Technology 、Streck
Elastin、biomax、Orflo Technologies、Accegen、Advbiomart、genlantis、Matriks Biotek
Matriks Biotek、Cygnus Technologies LLC、Enzyme Research、Bio/Data Corporation
Greer Lab 、Solarbio、bangslabs、bioline、musechem、Novocastra
stemrd、hyphen-biomed、polyplus、moltox 、exiqon、pentapharm、verichemlabs
GenStar、ALZET、lucernatechnologies 、meridian、origene、zimmerpeacocktech
horizondiscovery、Reagents、megazyme、elisasystems………
所有生物試劑耗材都可以進口，特別是冷門品牌，均能給客戶購買到。價格優(yōu)，貨期短，可加急，快10天到貨；保證服務(wù)質(zhì)量，所有產(chǎn)品均提供售后服務(wù)。大部分客戶我們提供貨到付款服務(wù)，
公司自成立依靠過硬的服務(wù)和良好的信譽與各大企事業(yè)單位、科研單位建立長期合作?？蛻舭ū贝?，清華，地大，中科院各所，各大藥企等等。
專業(yè)訂購國內(nèi)外試劑耗材，常備現(xiàn)貨，一手貨源，歡迎合作。
請輸入賬號
請輸入密碼
請輸驗證碼
以上信息由企業(yè)自行提供，信息內(nèi)容的真實性、準(zhǔn)確性和合法性由相關(guān)企業(yè)負(fù)責(zé)，化工儀器網(wǎng)對此不承擔(dān)任何保證責(zé)任。
溫馨提示：為規(guī)避購買風(fēng)險，建議您在購買產(chǎn)品前務(wù)必確認(rèn)供應(yīng)商資質(zhì)及產(chǎn)品質(zhì)量。